Hansoh Pharmaceutical Group Company Limited
3692
Classificação em ações
#900
Hansoh Pharmaceutical Group Company Limited, an investment holding company,... Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China. The company provides products for therapeutic areas, including anti-infection, central nervous system, oncology, and metabolic and other diseases, as well as autoimmune diseases. Its principal products include Ameile, Hansoh Xinfu, Pulaile, Zefei, Xintai, Xinmei, Gainuo, Tanneng, and Pulaitan; Hengmu, Mailingda, Hengsen, Oulanning, Ailanning, and Ameining; XINYUE; and Saint Luolai, Fulaimei, Ruibote, Fulaidi, Fulairui, Punuoan tablets, etc. It has licence agreements with GlaxoSmithKline Intellectual Property (No.4) Limited to develop, manufacture, and commercialize HS-20089 and HS-20093 for the treatment of patients with extensive-stage small-cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy; Biotheus Inc. to develop, produce, and commercialize bispecific antibody-drug conjugate product; and with Merck Sharp & Dohme LLC (MSD) to develop, manufacture, and commercialize HS-10535, an investigational pre-clinical oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist. The company was founded in 1995 and is headquartered in Shanghai, China. Hansoh Pharmaceutical Group Company Limited is a subsidiary of Stellar Infinity Company Ltd.
Preço da ação
$4.40
Valor de mercado
$26.66B
Variação (1 dia)
8.32%
Variação (1 ano)
-6.19%
País
CN
Negociar Hansoh Pharmaceutical Group Company Limited (3692)
Categoria
Healthcare
Histórico de dividendos de Hansoh Pharmaceutical Group Company Limited (3692)
Hansoh Pharmaceutical Group Company Limited (símbolo da ação: 3692) realizou um total de 8 pagamentos de dividendos.
A soma de todos os dividendos (ajustada para desdobramentos de ações) é: $1.00
Rendimento de dividendos (TTM): 0.0154
A soma de todos os dividendos (ajustada para desdobramentos de ações) é: $1.00
Rendimento de dividendos (TTM): 0.0154
Pagamentos de dividendos de Hansoh Pharmaceutical Group Company Limited (3692) de 2021 a 2026
Pagamentos anuais de dividendos
| Ano | Dividendo (ajustado para desdobramentos) | Alterar |
|---|---|---|
| 2026 (TTM) | $0.2316 | -36.88% |
| 2025 | $0.3669 | 6.91% |
| 2024 | $0.3432 | 184.34% |
| 2023 | $0.1207 | 34.11% |
| 2022 | $0.09 | 16.73% |
| 2021 | $0.0771 | 0.00% |
Lista de todos os pagamentos de dividendos
| Ano | Dividendo | Alterar |
|---|---|---|
| 2026 (TTM) | $0.2316 | -36.88% |
| 2025 | $0.3669 | 6.91% |
| 2024 | $0.3432 | 184.34% |
| 2023 | $0.1207 | 34.11% |
| 2022 | $0.09 | 16.73% |
| 2021 | $0.0771 | 0.00% |
Dividendos de empresas semelhantes ou concorrentes
| Empresa | Número de pagamentos de dividendos | País |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 38.00% |
IN
|
